{'fraction_non_alphanumeric': 0.01930240433457501, 'fraction_numerical': 0.0033863867253640365, 'mean_word_length': 5.179916317991632, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Instructions to Authors—1995

1 . The Journal of Neurochemistry is devoted to the prompt publication of high-quality original findings in areas relevant to molecular, chemical, and cell biological aspects of the nervous system. Papers which are wholly pharmacological, histochemical, or immunological, and methods papers or the cloning of confirmatory sequences which do not advance knowledge in neurochemistry will not normally be considered . Although papers in any area of neurochemistry will be considered, the Journal particularly encourages submissions in the areas of molecular and cellular biology. Papers that require extensive revision or further experimentation will be rejected . When revision is needed, such revision must be done within 2 months . 2. Three types of papers are considered : (a) Full papers should be written in the style described in section III . The more concise and well written a paper, the more rapidly it will be processed. (b) Rapid Communications are brief papers which present new ideas or data of particular originality and timeliness . The criteria for acceptance of Rapid Communications will be more stringent than for full papers . Decisions on acceptability will be made within one month of receipt and papers will normally be published within three months of acceptance . (c) Short Reviews usually are invited but unsolicited reviews can be considered and will be subjected to rigorous editorial assessment. 3 . Submission of a paper in the Journal ofNeurochemistry will be held to imply that it represents original research not previously published (except as an abstract or preliminary report), that it is not being considered for publication elsewhere, and that, if accepted, it will not be published elsewhere in similar form, in any language, without the consent of the International Society for Neurochemistry. Each person listed as an author is expected to have participated in the study to a significant extent . Although the editors and referees make every effort to insure the validity of published papers, the final responsibility rests with the authors, not with the Journal, its editors, or publisher . 4. All authors are expected to abide by accepted ethical standards. In investigations that involve human subjects or laboratory animals, authors shouldprovide an explicit statement in Materials and Methods/Experimental Procedures that the experimental protocols were approved by the appropriate institutional review committee and meet the guidelines of their responsible governmental agency . The steps taken to avoid unjustified procedures and discomfort should be stated. In the case of human subjects informed consent is essential. 5. Publication of descriptions of new recombinant nucleic acid or monoclonal antibody preparations will be on the understanding that the authors are willing, where possible, to supply samples of such materials in response to reasonable scientific requests .